Cargando…

Aberrant MUC1-TRIM46-KRTCAP2 Chimeric RNAs in High-Grade Serous Ovarian Carcinoma

High-grade serous ovarian cancer (HGSC) is among the most lethal forms of cancer in women. By analyzing the mRNA-seq reads from The Cancer Genome Atlas (TCGA), we uncovered a novel cancer-enriched chimeric RNA as the result of splicing between MUC1, a highly glycosylated transmembrane mucin, TRIM46,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kannan, Kalpana, Kordestani, Gona Karimi, Galagoda, Anika, Coarfa, Cristian, Yen, Laising
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695878/ https://www.ncbi.nlm.nih.gov/pubmed/26492273 http://dx.doi.org/10.3390/cancers7040878

Ejemplares similares

CDKN2D-WDFY2 Is a Cancer-Specific Fusion Gene Recurrent in High-Grade Serous Ovarian Carcinoma
por: Kannan, Kalpana, et al.
Publicado: (2014)

Aberrant chimeric RNA GOLM1-MAK10 encoding a secreted fusion protein as a molecular signature for human esophageal squamous cell carcinoma
por: Zhang, Hao, et al.
Publicado: (2013)

Chimeric RNA Design Principles for RNA-Mediated Gene Fusion
por: Gupta, Sachin Kumar, et al.
Publicado: (2022)

Changes in Environmental Stress over COVID-19 Pandemic Likely Contributed to Failure to Replicate Adiposity Phenotype Associated with Krtcap3
por: Szalanczy, Alexandria M, et al.
Publicado: (2023)

Antibodies to TRIM46 are associated with paraneoplastic neurological syndromes
por: van Coevorden‐Hameete, Marleen H., et al.
Publicado: (2017)

Epigenetic Variability across Human Populations: A Focus on DNA Methylation Profiles of the KRTCAP3, MAD1L1 and BRSK2 Genes
por: Giuliani, Cristina, et al.
Publicado: (2016)

Aberrant methylation of MUC1 and MUC4 promoters are potential prognostic biomarkers for pancreatic ductal adenocarcinomas
por: Yokoyama, Seiya, et al.
Publicado: (2016)

Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice
por: Gheybi, Elaheh, et al.
Publicado: (2018)

A VHH-Based Anti-MUC1 Chimeric Antigen Receptor for Specific Retargeting of Human Primary T Cells to MUC1-Positive Cancer Cells
por: Rajabzadeh, Alireza, et al.
Publicado: (2021)

The Construction of Chimeric T-Cell Receptor with Spacer Base of Modeling Study of VHH and MUC1 Interaction
por: Pirooznia, Nazanin, et al.
Publicado: (2011)

Chimeric Free Fibula Flap: An Encounter With Aberrant Anatomy
por: Brummund, Dieter, et al.
Publicado: (2020)

Trim46 contributes to the midbrain development via Sonic Hedgehog signaling pathway in zebrafish embryos
por: Jung, Jangham, et al.
Publicado: (2021)

Identification of aberrantly expressed long non‐coding RNAs in ovarian high‐grade serous carcinoma cells
por: Nakashima, Kengo, et al.
Publicado: (2020)

TRIM21 Dysfunction Enhances Aberrant B-Cell Differentiation in Autoimmune Pathogenesis
por: Kunishita, Yosuke, et al.
Publicado: (2020)

TRIM21 chimeric protein as a new molecular tool for multispecies IgG detection
por: Ramos, Anelize Felicio, et al.
Publicado: (2022)

Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression
por: Cheasley, Dane, et al.
Publicado: (2022)

Identification of core aberrantly expressed microRNAs in serous ovarian carcinoma
por: Chen, Steven F., et al.
Publicado: (2018)

The identification of a spontaneous 47, XX, +21/46, XY chimeric fetus with male genitalia
por: Lee, Kuei-Fang, et al.
Publicado: (2012)

Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignancies
por: Stasenko, Marina, et al.
Publicado: (2021)

MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance
por: Betge, Johannes, et al.
Publicado: (2016)

Aberrant over-expression of COX-1 intersects multiple pro-tumorigenic pathways in high-grade serous ovarian cancer
por: Wilson, Andrew J., et al.
Publicado: (2015)

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis
por: Blixt, Ola, et al.
Publicado: (2011)

High Levels of Genomic Aberrations in Serous Ovarian Cancers Are Associated with Better Survival
por: Baumbusch, Lars O., et al.
Publicado: (2013)

Chlamydia trachomatis and Anti-MUC1 Serology and Subsequent Risk of High-Grade Serous Ovarian Cancer: A Population-Based Case–Control Study in Northern Sweden
por: Jonsson, Sarah, et al.
Publicado: (2019)

Efficacy of CD46-targeting chimeric Ad5/35 adenoviral gene therapy for colorectal cancers
por: Cho, Young-Suk, et al.
Publicado: (2016)

Expression of MUC1 and MUC4 in Gallbladder Adenocarcinoma
por: Kim, Su-Mi, et al.
Publicado: (2012)

The testis-specific serine proteases PRSS44, PRSS46, and PRSS54 are dispensable for male mouse fertility(†)
por: Holcomb, Richard J, et al.
Publicado: (2020)

Mmu-miR-1894-3p Inhibits Cell Proliferation and Migration of Breast Cancer Cells by Targeting Trim46
por: Zhang, Li, et al.
Publicado: (2016)

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2015)

Associations between the Expression of Mucins (MUC1, MUC2, MUC5AC, and MUC6) and Clinicopathologic Parameters of Human Breast Ductal Carcinomas
por: Do, Sung-Im, et al.
Publicado: (2013)

Concurrent Primary Peritoneal Low-Grade Serous Carcinoma and Endometrial High-Grade Serous Carcinoma
por: Lockyer, Megan G., et al.
Publicado: (2015)

Degradation of MUC7 and MUC5B in Human Saliva
por: Takehara, Sachiko, et al.
Publicado: (2013)

Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)
por: Hanson, Ryan L., et al.
Publicado: (2016)

Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations
por: Hollis, Robert L., et al.
Publicado: (2018)

Identification TRIM46 as a Potential Biomarker and Therapeutic Target for Clear Cell Renal Cell Carcinoma Through Comprehensive Bioinformatics Analyses
por: Ren, Xiang-bin, et al.
Publicado: (2021)

TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells
por: Tantai, Jicheng, et al.
Publicado: (2022)

Bilateral Serous Psammocarcinoma of Ovary: Rare Variant Low Grade Serous Carcinoma
por: Jena, Saubhagya Kumar, et al.
Publicado: (2015)

Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS)
por: Buyuk, Melek, et al.
Publicado: (2023)

The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer
por: Duncan, Timothy J, et al.
Publicado: (2007)

Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gpn4lgn79qk2bnioc1p7gh1p2f